on 4 Nov 2011
Last Applicant/ Owned by
Crown Bioscience UK Limited
Building 14 Dodgeford Lane, Osgathorpe, Loughborough, Leicestershire
, , LE12 9TE
Serial Number
UK00002600285 filed on 4th Nov 2011
Registration Number
UK00002600285 registered on
10th Feb 2012
Correspondent Information
Urquhart-Dykes & Lord LLP
Arena Point, Merrion Way
Leeds,
LS2 8PA
Printed matter; printed publications; information, instructional and teaching materials; printed matter, printed publications, information, instructional and teaching materials relating to scientific and technological services and research and design relating to the same; printed matter, printed publications, information, instructional and teaching materials relating to industrial analysis; printed matter, printed publications, information, instructional and teaching materials relating to pre-clinical research and development; printed matter, printed publications, information, instructional and teaching materials relating to oncology research, analysis and development; printed matter, printed publications, information, instructional and teaching materials relating to pre-clinical efficacy assessments, therapeutic evaluations, post clinical studies and/or evaluations of cancer medicines.
Scientific and technological services and research and development relating thereto; industrial analysis and research services; pre-clinical research and development services; research and development services for pharmaceutical and/or biotechnological compound development; scientific and technological services and research and design relating thereto concerning oncology; pre-clinical research and development relating to oncology; oncology research, analysis and development; research, analysis, monitoring and development of pre-cancerous lesions, primary tumours and metastasis; pre-clinical pharmaceutical studies; molecular profiling; molecular analysis; in-vitro studies; in-vivo model development; in-vivo mechanistic and therapeutic evaluations; post clinical study analysis; evaluation of cancer medicines; pre-clinical efficacy assessments; stem cell enrichment; assessment of primary tissue validation models.
UK00002600285
Word
Individual